Browsing Tag
European Commission
160 posts
Bristol Myers Squibb’s Opdivo and Yervoy combination approved for metastatic NSCLC in Europe
Bristol Myers Squibb (BMS) has announced a major breakthrough in cancer treatment with the European Commission’s (EC) approval…
Johnson & Johnson strikes key deal with EC for JNJ-78436735 Covid-19 vaccine supply
Johnson & Johnson (J&J) has announced a significant development in its efforts to combat the Covid-19 pandemic, revealing…
Kyowa Kirin secures extended EC approval for CRYSVITA in X-linked hypophosphataemia treatment
Kyowa Kirin has recently received expanded approval from the European Commission (EC) for its recombinant monoclonal antibody treatment,…
Gilead, Galapagos bag Jyseleca EC approval for rheumatoid arthritis
Jyseleca EC approval : Gilead Sciences and Galapagos have secured marketing authorization for Jyseleca (filgotinib 200 mg and…
AstraZeneca finalizes AZD1222 Covid-19 vaccine candidate deal with EC
AstraZeneca said that it has finalized a deal with the European Commission (EC) for the delivery of up…
CHMP adopts positive opinion for avapritinib for PDGFRA D842V mutant GIST
US precision therapy company Blueprint Medicines said that the Committee for Medicinal Products for Human Use (CHMP) of…
Gilead Sciences announces Veklury EU approval for COVID-19 treatment
Veklury EU approval : Gilead Sciences said that Veklury (remdesivir) has been given conditional marketing authorization from the…
Medivir gets orphan medicinal product designation for MIV-818 for HCC in EU
Swedish biotech company Medivir has secured orphan medicinal product designation from the European Commission for MIV-818 for the…
EC approves Reblozyl for transfusion-dependent anemia in adults
Bristol Myers Squibb and Acceleron Pharma have secured approval from the European Commission (EC) for their jointly developed…
Takeda gets extended EC approval for ADCETRIS in sALCL
Takeda Pharmaceutical has secured extended approval for ADCETRIS (brentuximab vedotin) in the European Union to include the treatment…